| Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target L Miele, G Marrone, C Lauritano, C Cefalo, A Gasbarrini, C Day, A Grieco Current Pharmaceutical Design 19 (29), 5314-5324, 2013 | 142 | 2013 |
| Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation A Nicoletti, FR Ponziani, M Biolato, V Valenza, G Marrone, G Sganga, ... World journal of Gastroenterology 25 (33), 4814, 2019 | 134 | 2019 |
| Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The Lancet Gastroenterology & Hepatology 3 (9), 626-634, 2018 | 126 | 2018 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 121 | 2020 |
| Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients FR Ponziani, F Del Zompo, A Nesci, F Santopaolo, G Ianiro, M Pompili, ... Alimentary pharmacology & therapeutics 52 (6), 1060-1068, 2020 | 83 | 2020 |
| Predicting in‐hospital mortality in COVID‐19 older patients with specifically developed scores M Covino, G De Matteis, ML Burzo, A Russo, E Forte, A Carnicelli, ... Journal of the American Geriatrics Society 69 (1), 37-43, 2021 | 75 | 2021 |
| Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins M Biolato, G Marrone, S Racco, C Di Stasi, L Miele, G Gasbarrini, ... Eur Rev Med Pharmacol Sci 14 (4), 356-362, 2010 | 75 | 2010 |
| The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease M Sanduzzi Zamparelli, D Compare, P Coccoli, A Rocco, OM Nardone, ... International journal of molecular sciences 17 (8), 1225, 2016 | 68 | 2016 |
| Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease M Biolato, F Manca, G Marrone, C Cefalo, S Racco, GA Miggiano, ... World journal of gastroenterology 25 (4), 509, 2019 | 62 | 2019 |
| Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. G Marrone, FG Vaccaro, M Biolato, L Miele, A Liguori, C Araneo, ... European Review for Medical & Pharmacological Sciences 21, 2017 | 62 | 2017 |
| Assessment of neurological manifestations in hospitalized patients with COVID‐19 M Luigetti, R Iorio, AR Bentivoglio, L Tricoli, V Riso, J Marotta, C Piano, ... European journal of neurology 27 (11), 2322-2328, 2020 | 53 | 2020 |
| COVID-19 and intestinal inflammation: Role of fecal calprotectin V Ojetti, A Saviano, M Covino, N Acampora, E Troiani, F Franceschi, ... Digestive and Liver Disease 52 (11), 1231-1233, 2020 | 49 | 2020 |
| Fatty liver and drugs: the two sides of the same coin. L Miele, A Liguori, G Marrone, M Biolato, C Araneo, FG Vaccaro, ... European Review for Medical & Pharmacological Sciences 21, 2017 | 46 | 2017 |
| Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting L Miele, T De Michele, G Marrone, MA Isgrò, U Basile, C Cefalo, M Biolato, ... The International journal of biological markers 32 (4), 397-402, 2017 | 41 | 2017 |
| Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms L Miele, G Cammarota, V Vero, S Racco, C Cefalo, G Marrone, M Pompili, ... Digestive and Liver Disease 44 (12), 1032-1036, 2012 | 34 | 2012 |
| Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients V Nociti, M Biolato, C De Fino, A Bianco, FA Losavio, M Lucchini, ... Brain and behavior 8 (6), e00968, 2018 | 31 | 2018 |
| Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets L Miele, MA Alberelli, M Martini, A Liguori, G Marrone, A Cocomazzi, ... Translational Research 231, 24-38, 2021 | 29 | 2021 |
| Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate … AM De Gaetano, M Catalano, M Pompili, MG Marini, P Rodríguez Carnero, ... European Review for Medical & Pharmacological Sciences 23 (18), 2019 | 28 | 2019 |
| Liver transplantation for drug-induced acute liver failure. M Biolato, C Araneo, G Marrone, A Liguori, L Miele, FR Ponziani, ... European Review for Medical & Pharmacological Sciences 21, 2017 | 28 | 2017 |
| Sarco‐Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation Q Lai, P Magistri, R Lionetti, AW Avolio, I Lenci, V Giannelli, A Pecchi, ... Liver International 41 (7), 1629-1640, 2021 | 21 | 2021 |
Antonio GriecoProfessore associato, Università cattolica del sacro cuore, Facoltà di Medicina e Chirurgia A. Gemelli, Roma在 rm.unicatt.it 的电子邮件经过验证
